Keywords: inhibitex, announces, 50m, financing, biopharmaceutical, company, focused

Inhibitex announces $50M financing

Article | 15 November 2004

Inhibitex, a US biopharmaceutical company focused on the development of antibody-based products, has entered into definitive purchase agreements to raise ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Baygam

Immune Globulin

Gammagard

Go to drug listing